1 / 4

Global Bioanalytical Testing Services Market

Bioanalytical Testing Services Market is valued at USD 2.90 Billion in 2018 and expected to reach USD5.61 Billion by 2025 with the CAGR of 9.87% over the forecast period.

shubhamgosavi
Télécharger la présentation

Global Bioanalytical Testing Services Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Bioanalytical Testing Services Market is valued at USD 2.90 Billion in 2018 and expected to reach USD5.61 Billion by 2025 with the CAGR of 9.87% over the forecast period. Rise in demand for bioanalyctical services, large number of ongoing clinical trials, huge investment by many of the major pharmaceutical companies is one of the primary factors driving growth of the global Bioanalytical Testing Services Market. Bioanalytical testing is the analytical method used for the analysis of biotechnological or biological products. Bioanalytical testing services supports development of drugs in various geographies and for various different therapeutic areas. Bioanalytical testing enables quantitative determination of drugs in biological substances such as blood, serum, plasma, or urine. All these tests are conducted in pathological labs or diagnostic centers and in research laboratories. It is conducted when a drug is being developed, and helps in the commercialization of the drug sells. There are various types of test available such as pharmacokinetic test, pharmacodynamics test, bioequivalence test, bioavailability test and other test. Among the entire bioavailability and bioequivalence test are expected to gain significant growth of the global bioanalytical testing services market due to increased demand for bioanalytical testing services in generic drug development. Pharmaceutical and biopharmaceutical companies are the leading end-user in bioanalytical testing services. Bioanalytical testing services market report is segmented on the basis test type, application, end-user and by regional & country level. Based upon test type, global bioanalytical testing services market is segmented into absorption distribution metabolism excretion (ADME), pharmacokinetics (PK), pharmacodynamics (PD), bioavailability, bioequivalence and others. Based upon application, global bioanalytical testing services market is segmented into oncology, neurology, infectious diseases, gastroenterology, cardiology and other. Based upon end-user, global bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations and contract research organizations. Get Sample Copy of This Premium Report: @ https://industrystatsreport.com/Request/Sample?ResearchPostId=12894&RequestType=Sample The regions covered in this bioanalytical testing services market report are North America, Europe, Asia- Pacific and Rest of the World. On the basis of country level, market of bioanalytical testing services is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. Bioanalytical Testing Services Vendors Covance Inc. LabCorp inVentiv Health Toxikon, Inc.

  2. Charles River Laboratories International, Inc. PPD, ICON plc Pace Analytical Services, LLC. Sartorius Stedim BioOutsource Limited. SGS SA Frontage Holdings Corporation Fios Genomics Intertek group. Particle Sciences Lotus Labs Pvt. Ltd. Others. Bioanalytical Testing Services Market Dynamics – Rise in demand for bioanalyctical services, large number of ongoing clinical trials, huge investment by many of the major pharmaceutical companies are key factors driving growth of the global bioanalytical testing services market. Moreover, rising spending on pharmaceutical and launch of high number of novel drugs are an impelling factor for new drug development, which impacts positively the growth of the bioanalytical testing services market in forcaste period. According to National Conference of State Legislatures, as of 2015, about 36 % of total pharmaceutical spending in the commercial market was devoted to specialty medications. According to The Centers for Medicare & Medicaid Services (CMS), projects continued increases in drug spending of 6% or more annually from 2015 to 2022, as both drug prices and utilization increase. Moreover, Lack of skilled professionals is the major restrains of the global bioanalytical testing services market. However, technological advancements and developed healthcare infrastructure and advance analytical instruments for testing may generate new opportunities in forecast period. The global pharmaceutical market will reach nearly USD 1,430 billion by 2020, According to International Federation of Pharmaceutical Manufacturers & Associations. Bioanalytical Testing Services Market Regional Analysis – North America is expected to dominate region with highest shares due to heavy investments in R&D initiatives, to rise in demand for bioanalyctical services, large number of ongoing clinical trials, presence of highly reliable, complex, and high-end pharmaceuticals, technological expansions and integration of pioneering technologies ,occurrence of lifestyle related diseases, major players present in the region. According to National Health Expenditures Report, U.S. health care spending increased 3.9 percent to

  3. Request for Methodology: @ https://industrystatsreport.com/Request/Sample?ResearchPostId=12894&RequestType=Methodolog y reach USD 3.5 trillion or USD 10,739 per person in 2017. Gross domestic product (GDP) spending related to health care was 17.9 percent in 2017. According to International Federation of Pharmaceutical Manufacturers & Associations, The United States share of the global market will increase from 40.3% to 41% in2015 to 2020. As per The International Federation of Pharmaceutical Manufacturers & Associations, the research-based pharmaceutical industry currently spends over USD 149.8 billion on pharmaceutical R&D per year. Moreover, due to fast development of new pharmaceutical industries, major merges and acquisitions among pharmacies, are some major factors increasing the growth of bioanalytical Testing Services market during the forecast period. For instance, Laboratory Corporation of America (LabCorp) acquired Covance. This transaction is expected to expand the biopharmaceutical reach of LabCorp globally, thus promoting higher profits and number of projects. Asia Pacific market is witnessing strong growth due large population rate, growing prevalence of chronic diseases, rising adoption of advanced technologies. As per World Health Organisation, Chronic disease risks and deaths are increasing rapidly, especially in low and middle income countries. According to WHO, almost 23.6 million people will die from CVDs, mainly from heart disease and stroke by 2030. Also, the growth of biopharmaceutical industry in China and India is expected to grow bioanalytical testing services market over the forecast period. Key Benefits for Bioanalytical Testing Services Market Reports – Global Market report covers in depth historical and forecast analysis. Global Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level. Global Market report helps to identify opportunities in market place. Global Market report covers extensive analysis of emerging trends and competitive landscape. Bioanalytical Testing Services Market Segmentation – By Test Type:- Absorption Distribution Metabolism Excretion (ADME) (In-Vivo, In-Vitro), Pharmacokinetics (PK), Pharmacodynamics (PD), Bioavailability, Bioequivalence, Others By Application:- Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology, Other By End-User:- Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, Contract Research Organizations Regional & Country Analysis North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan,

  4. India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa Buy Now @ https://industrystatsreport.com/Buy/Create/12894/Buy/SingleUser About Us: Brandessence Market Research and Consulting Pvt. ltd. Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London. Contact us at: +44-2038074155 or mail us at sales@industrystatsreport.com

More Related